Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
As the only chk1 in the clinic. Its us by default.
The big untreatable cancers (in some mutations )
Pancreatic
Ovarian
Sclc
All c $10bn pa markets. Preclinical papers from the best researchers globally (MD Anderson centre and ICR). Showing near complete regression with a 737 combo. Any one is a 20 bag minimum from here. Educated gambling ;)
Nice one citizen. Wee1 mentioned. As i was browsing patents today. Noticed sierra has filed a patent on sra737 as a combo with the wee1 azd1775 aka mk1775 (joint compound between astra and merck). Those with an attention span longer than a gnat will know astra brought azd1775 vack from the dead a few months ago. The combo seems particularly effective in ovarian. If only the analysts did some proper research they would have made a house today. ;)
The gerbil was glad to die imho inbetween rajesh and xereus and a swan vesta
https://youtu.be/cTrOb8zyrZk
One of the mms (not ph) got their spotty herberts to try a short on imperfect and incomplete info. I still make it c 50m shares they are missing. I and several others have reinstated limit sells. Its called a bear trap. And i shall have a lovely lie in whilst Rajesh my uber eats driver learns his lesson not to hack my wifi. Have a lovely tuesday. ;)))
Mike. We are in a curious transitioning phase. On thinly traded aim stocks charts are a bit useless. Its news then spike. Then momentum chasers then drops. Mcap is now good. More large punters. I would describe it as early puberty for us in the chart world. Have a look at the p&f chart though. Very very cute
Bailiff. Personally scarlette douglas and a packet of wotsits relieves the pain. But unsurprisingly tyk2 jak1 (il6. Il15) may also be a cure. I kid you not.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480430/
Re crystalline patent. Great. Patented. Royalties.
As per my recollection ( which may be flawed) sareum have never said orginal formulation was "solid". Only that it was oral. Happy to be proved wrong but a key difference.
Some case studies. I still think putting the current formulation into p1 is actually a de risk and an npv bòost. Imho.
https://aapsopen.springeropen.com/articles/10.1186/s41120-016-0003-4
30% now. 60% later better than a year fannhing about with 6 crystalline forms.
Dont know either. But.
1. Volume precedes the rise. Usually by 2 to 3 weeks. We had excellent volume.
2. Its a market. Some parties have information. Others dont. Even the bod may not be privy to the info or why (not the first time )
3. Personally. Dyor. I still think the market hasnt caught up with the science. Even a lot of the scientists havent caught up.
4. Sepsis (gates). Tyk2 (world big pharma). Biodefence (darpa US plus various **** youll never hear about).
All worth over a quid individually. Ill trust my research and the volume support tells me news in c weeks. Gla as ever.
Although this variant may not be too deadly (we wont know). We will get other variants following.
1. Borders arent closed so cross transmission andvnot isolating outbreak areas.
2. C19 is very rare in that humans infect wild animals. So will be circulating in the wild and mutating a while yet.
3. New vaccines 3 months to develpp 6 months to scale up production
4. Merck pill not so effective
5. Antivirals encourage mutations (not a good sulution)
6. Mabs to be rationed as they dont have the stock.
7. Immune compromised people act as petri dishes for new combinations. (Suspect its no coincidence southern african countries have historically high levels of aids and therefore antiviral use).
There is a certain inevitabily of a global planb for treatments acceleration. Agile isnt the only route. And if money wasnt an issue id be looking to get the existing oral formulation into p1 asap. Then the capsule later. If someone else pays for it. I suspect someone might. Gla
Wrong link apols
https://youtu.be/XbQ08Ixczvo
All legal. They dont even have to report large trades for 3 months. Trust your gut. Something is afoot. I dont know what. And in the meantime the lovely norah jones (jazz) singing a metal classic. On the yacht list .. https://youtu.be/gD6cPE2BHic
Hot black was that an attempt at a hoiku ? We need so start with babysteps.
There was a young curate at kings
Who talked of god and such things
But his real desire
Was a boy in the choir
With a bottom like jelly on springs.
Feeling a bit frivolous. Dont google nantucket limericks. Dangerous path :)
Yup. Merchant banks. Brokers. Mms. Lose the effing house on inadequate risk controls and employing teenagers. Barings. Merchant house and too many brokers at cbot to name. ****ing amateurs . Back to sleep now
Didnt know it was removed.
https://youtu.be/gD6cPE2BHic
Imho. One mm engineered the squeeze and has 24 hours to settle their books. As the sage said. **** em. Going to be a fun 24 hours xxx
Mike. taleb an effing genius. Changed my outlook . So my takeaways were. Markets so automated only chance of making money is under researched microcaps. 2. Highly scaleable and licenceable intellectual property is the way to go. As a bonus anyone who describes themselves as a professional "flaneur" is already cool as **** in my book. Nursey says i need to back to bed and take my meds xxxx
Free pdf version available too
https://www.amazon.co.uk/Technical-Analysis-Financial-Markets-Comprehensive/dp/0735200661/ref=asc_df_0735200661/?tag=googshopuk-21&linkCode=df0&hvadid=500792593882&hvpos=&hvnetw=g&hvrand=7199460609721108579&hvpone=&hvptwo=&hvqmt=&hvdev=m&hvdvcmdl=&hvlocint=&hvlocphy=9045761&hvtargid=pla-433931155081&psc=1
Only 2 books you.need imho
Good luck